Literature DB >> 26431990

Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.

Haixue Zheng1, Kaiqi Lian2, Fan Yang2, Ye Jin2, Zixiang Zhu2, Jianhong Guo2, Weijun Cao2, Huanan Liu2, Jijun He2, Keshan Zhang2, Dan Li2, Xiangtao Liu3.   

Abstract

Foot-and-mouth disease (FMD) is a highly contagious vesicular disease that affects domestic and wild cloven-hoofed animals worldwide. Recently, a series of outbreaks of type A FMDV occurred in Southeast Asian countries, China, the Russia Federation, Mongolia, Kazakhstan and South Korea. The FMD virus (A/GDMM/CHA/2013) from China's Guangdong province (2013) is representative of those responsible for the latest epidemic, and has low amino acid identity (93.9%) in VP1 protein with the epidemic strain A/WH/CHA/09 from Wuhan, China in 2009. Both of isolates belong to the Sea-97 genotype of ASIA topotype. Therefore, the application of a new vaccine strain with cross-protective efficacy is of fundamental importance to control the spread of the two described pandemic strains. A chimeric strain rA/P1-FMDV constructed by our lab previously through replacing the P1 gene in the vaccine strain O/CHA/99 with that from the epidemic stain A/WH/CHA/09, has been demonstrated to exhibit good growth characteristics in culture, and the rA/P1-FMDV inactivated vaccine can provide protection against epidemic strain A/WH/CHA/09 in cattle. However, it is still unclear whether the vaccine produces efficient protection against the new pandemic strain (A/GDMM/CHA/2013). Here, vaccine matching and pig 50% protective dose (PD50) tests were performed to assess the vaccine potency. The vaccine matching test showed cross-reactivity of sera from full dose vaccine vaccinated pigs with A/WH/CHA/09 and A/GDMM/CHA/2013 isolates, with average r1 values of 0.94±0.12 and 0.68±0.06 (r1≥0.3), which indicates that the rA/P1-FMDV vaccine is likely to confer good cross-protection against the two isolates. When challenged with two pandemic isolates A/WH/CHA/09 and A/GDMM/CHA/2013 strain, the vaccine achieved 12.51 PD50 and 10.05 PD50 per dose (2.8μg), respectively. The results indicated that the rA/P1-FMDV inactivated vaccine could protect pigs against both A/WH/CHA/09 and A/GDMM/CHA/2013 pandemic isolates.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ASIA topotype; Engineering foot-and-mouth disease virus; Foot-and-mouth disease virus; Protective efficacy

Mesh:

Substances:

Year:  2015        PMID: 26431990     DOI: 10.1016/j.vaccine.2015.09.055

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  The Distribution of Different Clades of Seneca Valley Viruses in Guangdong Province, China.

Authors:  Pan Chen; Fan Yang; Weijun Cao; Huanan Liu; Keshan Zhang; Xiangtao Liu; Zhiwen Xu; Zixiang Zhu; Haixue Zheng
Journal:  Virol Sin       Date:  2018-10-16       Impact factor: 4.327

2.  Development and Validation of a Competitive ELISA Based on Bovine Monoclonal Antibodies for the Detection of Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype A.

Authors:  Yimei Cao; Kun Li; Xiangchuan Xing; Guoqiang Zhu; Yuanfang Fu; Huifang Bao; Xingwen Bai; Pu Sun; Pinghua Li; Jing Zhang; Xueqing Ma; Jian Wang; Zhixun Zhao; Dong Li; Zaixin Liu; Zengjun Lu
Journal:  J Clin Microbiol       Date:  2022-03-07       Impact factor: 11.677

3.  The Pseudoknot Region of the 5' Untranslated Region Is a Determinant of Viral Tropism and Virulence of Foot-and-Mouth Disease Virus.

Authors:  Zixiang Zhu; Fan Yang; Weijun Cao; Huanan Liu; Keshan Zhang; Hong Tian; Wen Dang; Jijun He; Jianhong Guo; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

4.  Evaluation of immunogenicity and cross-reactive responses of  vaccines prepared from two chimeric serotype O foot-and-mouth disease viruses in pigs and cattle.

Authors:  Pinghua Li; Shulun Huang; Jingjing Zha; Pun Sun; Dong Li; Huifang Bao; Yimei Cao; Xingwen Bai; Yuanfang Fu; Xueqing Ma; Kun Li; Hong Yuan; Jing Zhang; Zhixun Zhao; Jian Wang; Keqiang Zhang; Yingli Chen; Qiang Zhang; Shuyun Qi; Zaixin Liu; Zengjun Lu
Journal:  Vet Res       Date:  2022-07-08       Impact factor: 3.829

Review 5.  Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs.

Authors:  Nicholas A Lyons; Young S Lyoo; Donald P King; David J Paton
Journal:  Front Vet Sci       Date:  2016-11-30

6.  Design and development of a chimeric vaccine candidate against zoonotic hepatitis E and foot-and-mouth disease.

Authors:  Nouredine Behloul; Sarra Baha; Zhenzhen Liu; Wenjuan Wei; Yuanyuan Zhu; Yuliang Rao; Ruihua Shi; Jihong Meng
Journal:  Microb Cell Fact       Date:  2020-07-11       Impact factor: 5.328

7.  Immune Responses to Orally Administered Recombinant Lactococcus lactis Expressing Multi-Epitope Proteins Targeting M Cells of Foot-and-Mouth Disease Virus.

Authors:  Fudong Zhang; Zhongwang Zhang; Xian Li; Jiahao Li; Jianliang Lv; Zhongyuan Ma; Li Pan
Journal:  Viruses       Date:  2021-10-09       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.